NEW YORK, Aug. 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This report analyzes the worldwide markets for Peripheral Arterial Disease (PAD) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 50 companies including many key and niche players such as 7TM Pharma A/S, AnGes MG, Inc., AstraZeneca Plc, CardioVascular BioTherapeutics, Inc., Cytokinetics, Inc., Diffusion Pharmaceuticals LLC, Eli Lilly and Company, LTT Bio-Pharma Co., Ltd., miRagen Therapeutics, Inc., Multi Gene Vascular Systems Ltd., Nissan Chemical Industries, Ltd., Otsuka Pharmaceutical Co., Ltd., Pluristem Therapeutics, Inc., ReNeuron Group PLC., Sanofi , Sucampo Pharmaceuticals, Inc., t2cure GmbH, TCA Cellular Therapy, LLC , TheraVasc, Inc., and vasopharm GmbH. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
To order this report:
Email: [email protected]
Intl: +1 805-652-2626